2023-08-22 17:22:02 ET
More on Karuna Therapeutics
- Karuna's Robust Liquidity Paves Way For KarXT Milestones (Rating Upgrade)
- Karuna Therapeutics, Inc. ( KRTX ) Q2 2023 Earnings Call Transcript
- Karuna Therapeutics: Great Company, But Not A Great Buy Right Now
- Royalty Pharma, PureTech in pact for royalties in Karuna’s lead asset
- Karuna extends selloff while Wall Street backs schizophrenia candidate
- Karuna Therapeutics extends decline on $400M stock offering
- Karuna/ Zai Lab succeed in late-stage trial for schizophrenia candidate
- Seeking Alpha’s Quant Rating on Karuna Therapeutics
- Earnings data for Karuna Therapeutics
For further details see:
Wells Fargo starts Karuna at overweight, cites schizophrenia drug candidate